1.
Data from French named patient program of quizartinib in relapsed/refractory acute myeloid leukemia.
Leuk Lymphoma
; 62(7): 1756-1760, 2021 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33596765